Infinium Global Research Glycated Hemoglobin Testing Market | Page 2

Glycated Hemoglobin Testing Market: Trends and Forecast -2024
The Infinium Global Research analyzes the report of Glycated Hemoglobin Testing
Market over the period of 2018 to 2024. This report also provides detailed
qualitative and quantitative analyses of the market dynamics, market size and
future trends in Global Glycated Hemoglobin Testing Market. It will help a lot of
decision makers to develop strategies and find new opportunities in the Global
markets of Glycated Hemoglobin Testing.
The report covers market changing aspects including drivers, restraints,
opportunities, and trends expected to encouragement the expansion of the
Glycated Hemoglobin Testing Market during the said period. The report also
provides market attractiveness analysis, by geography, and market share analysis,
by key players respectively. Some of the prominent participants in the Global
Glycated Hemoglobin Testing Market are Danaher Corporation, Roche Holdings AG,
Randox Laboratories Ltd., Siemens AG, Sebia SA, A. Menarini Diagnostics Ltd. and
Trinity Biotech Inc. According to report the global glycated hemoglobin testing
market is projected to grow at a CAGR of 8.9% over the forecast period of 2018-
2024.
For More Details Get Free Few Sample Pages of this Premium Report: -
https://www.infiniumglobalresearch.com/reports/sample-request/1840
The glucose molecules in the blood normally wedged with the hemoglobin
molecules present in the blood so the hemoglobin has become glycosylated. The
glycated hemoglobin is the one form of hemoglobin that used to measured average
plasma glucose concentration. The glycated hemoglobin testing is measure amount
of glycosylated hemoglobin in the blood. Glycated hemoglobin test show the blood
glucose levels over the past six to eight weeks and help to determine how the
diabetes is being controlled over time.
The rapidly growing occurrence of diabetes across the globe drives the growth of
the glycated hemoglobin test market. According to the WHO, 422 Million adults
have been diagnosed with diabetes globally and it has been steadily increasing in
the low level and middle level people. The diabetes is one of the leading cause of
death in the world so the need for effective and accurate tests to determine and
control the diabetes are rising very rapidly. The rising geriatric population and
growing awareness about the diabetes are contributing in the growth of the
glycated hemoglobin market. However, high costs associated with glycated
hemoglobin testing devices is hampering the growth of the glycated hemoglobin
2
© Infinium Global Research